Skip to main content

MGC Pharmaceuticals (ASX:MXC) logo MGC Pharmaceuticals Health Care
Biotech Cannabis Healthcare Pharmaceuticals

$0.005 (0%)

High

$0.01

Low

$0.00

Trades

68

Turnover

$72,477

Volume

14,697,042
30 June 2023 at 4:10pm
If you were already registered, log in here.
MXC Announcements on Price Chart

Latest Announcements

Headline Date
Details of Company Address 30 June 2023 at 5:55pm
Company Update 30 June 2023 at 5:45pm
Results of Meeting 29 June 2023 at 7:05pm
s708A(5)(e) Cleansing Notice 21 June 2023 at 5:20pm
Application for quotation of securities - MXC 21 June 2023 at 5:20pm
Final Director's Interest Notice x 2 1 June 2023 at 3:30pm
Initial Director's Interest Notice 1 June 2023 at 3:30pm
Appointment of Non-Executive Director 1 June 2023 at 3:30pm
First CannEpil Delivered to UK Patients 31 May 2023 at 9:30am
Corporate Update - Board and UK Adviser Changes 30 May 2023 at 3:35pm
Notice of General Meeting/Proxy Form 30 May 2023 at 1:35pm
Distribution of General Meeting Documents - Notice of Access 30 May 2023 at 1:35pm
Change in Director's Interests x 5 5 May 2023 at 6:25pm
s708A(5)(e) Cleansing Notice 5 May 2023 at 6:10pm
Application for quotation of securities - MXC 5 May 2023 at 6:00pm
Application for quotation of securities - MXC 5 May 2023 at 5:59pm
Notification regarding unquoted securities - MXC 5 May 2023 at 5:50pm
Notification of cessation of securities - MXC 5 May 2023 at 5:45pm
Malta Production Facility Receives EU-GMP Approval 2 May 2023 at 9:25am
Quarterly Activities/Appendix 4C Cash Flow Report 28 April 2023 at 10:25am
s708A(5)(e) Cleansing Notice 20 April 2023 at 6:05pm
Notification regarding unquoted securities - MXC 20 April 2023 at 5:55pm
Application for quotation of securities - MXC 20 April 2023 at 5:50pm
Becoming a substantial holder 18 April 2023 at 9:15am
s708A(5)(e) Cleansing Notice 14 April 2023 at 6:00pm
Application for quotation of securities - MXC 14 April 2023 at 6:00pm
Proposed issue of securities - MXC 13 April 2023 at 10:25am
Proposed issue of securities - MXC 13 April 2023 at 10:25am
Fundraise closed raising up to a total of GBP 2.09m 13 April 2023 at 10:25am
CannEpil now available by Named Patient Request in UK 11 April 2023 at 5:35pm
MGC Pharma Investor Presentation April 2023 11 April 2023 at 5:30pm
Funding Commitments Received for GBP 1.8m 11 April 2023 at 5:20pm
Trading Halt 11 April 2023 at 9:55am
MGC Receive Permission for Psilocybin Research & Development 3 April 2023 at 9:05am
Notification of cessation of securities - MXC 3 April 2023 at 8:35am
Results of Meeting 30 March 2023 at 8:05pm
ArtemiC Listed as OTC Drug in USA, AMC Places US$2m Order 21 March 2023 at 9:40am
First patient enrolled in MGC ZAM App CannEpil Trial 15 March 2023 at 10:00am
Notification regarding unquoted securities - MXC 9 March 2023 at 6:05pm
Provision of US$500,000 Funding 8 March 2023 at 3:50pm
s708A(12C)(e) Cleansing Notice 8 March 2023 at 3:40pm
Proposed issue of securities - MXC 8 March 2023 at 3:30pm
Completion of CimetrA Mechanism of Action study 7 March 2023 at 10:15am
Appointment of UK Lead Broker Change of Company Secretary 1 March 2023 at 6:40pm
s708A(5)(e) Cleansing Notice 28 February 2023 at 7:25pm
Application for quotation of securities - MXC 28 February 2023 at 7:20pm
Half Year Accounts 28 February 2023 at 7:05pm
Notice of General Meeting/Proxy Form 28 February 2023 at 1:55pm
Distribution of General Meeting Documents - Notice of Access 28 February 2023 at 1:40pm
Investor Presentation 10 February 2023 at 7:10pm
If you were already registered, log in here.